Pharmacology & ToxicologyCytotherapyPeer-reviewed
Transforming clinical apheresis waste into a renewable source of patient-derived CD34+ hematopoietic stem cell biobank for beta-hemoglobinopathy research and therapeutic discovery
Jun Liu, Shin‐Young Park, Hirotomo Nakahara…·Li Chai
This paper describes a method to recover and biobank CD34+ hematopoietic stem cells from clinical apheresis waste for hemoglobinopathy research, showing comparable yields and viability to peripheral blood samples.
DOI 10.1016/j.jcyt.2026.103056